Search
Assembly Biosciences Inc
ASMBAdd to Watchlist
25.110USD
-0.950-3.65%
Close 07-31 16:00（ET）Quotes delayed by 15 min
497.60MMarket Cap
274.55P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Assembly Biosciences Inc is 9.00, ranking 16 out of 385 in the Biotechnology & Medical Research industry. The average price target is 39.50, with a high of 50.00 and a low of 35.00.
Analyst Rating
Based on
4
analysts
Strong Buy
Current Rating
50.000
Target Price
+99.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Assembly Biosciences Inc
ASMB
4
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Assembly Biosciences Inc's expected revenue for the next quarter?
Assembly Biosciences Inc's expected revenue is 8.60M.
What is Assembly Biosciences Inc's price target?
Analysts forecast that Assembly Biosciences Inc's price target is USD 39.50, with the highest forecast at USD 50.00 and the lowest forecast at USD 35.00.
How have Assembly Biosciences IncASMB's recent earnings per share performed?
The market expectation was USD -0.54, while Assembly Biosciences IncASMB's earnings per share (EPS) for the previous quarter was USD 1.30. EPS for the next quarter is expected at USD -0.65.
What is the analyst rating for Assembly Biosciences Inc?
Based on the ratings of Assembly Biosciences Inc's stock from 4 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.